MED-EL Unveils SONNET 3 Cochlear Implant Audio Processor in India

In September 2026, MED-EL unveiled SONNET 3, which is a cochlear implant audio processor, at CIGICON 2026, the yearly conference of the Cochlear Implant Group of India (CIGI). This event took place from 4th to 6th September 2026 at the Jaypee Palace Hotel and Convention Centre, Agra, Uttar Pradesh, India. This launch shows the efforts of the company to make modern hearing technologies accessible to cochlear implant users in India.

SONNET 3 has the smallest size and the least weight in the current behind-the-ear audio processor lineup of the company. It has an ergonomic design and is also equipped with integrated direct streaming, enabling users to stream phone calls and music directly from compatible Android and Apple smartphones, without the requirement for any additional hardware.

SONNET 3 also has dual microphones and Automatic Sound Management (ASM 3.0) technology, which helps it to auto-adapt to the hearing settings and decrease background noise so that users can participate in conversations smoothly. The processor is IP68 standard-grade waterproof, and its compact, tamper-resilient design, with specialized wearing and fixation options, enables it to be appropriate for use by children.

The CIGICON 2026 event saw the presence of ENT surgeons, audiologists, habilitationists, and hearing-care experts from all over India as well as neighboring nations to discuss medical experiences, enhancements in cochlear implantation, and methodologies to deliver better treatments.

Impact on the Healthcare Industry

According to Precedence Research, the launch of SONNET 3 in India is expected to benefit people with hearing issues as they look to participate in routine conversations and perform everyday tasks. This development will also help them from a safety point of view, as this device will help them hear vehicle horns clearly as they walk on roads. Cochlear implants are used in people with severe hearing loss, where hearing aids can no longer help. A hearing aid amplifies the sound, but a cochlear implant bridges the gap of non-functional ear parts and stimulates the auditory nerve.

Impact on the Cochlear Implant Market

The global cochlear implant market size is valued at USD 2.42 billion in 2025 and is predicted to increase from USD 2.63 billion in 2026 to approximately USD 5.23 billion by 2035, expanding at a CAGR of 8.01% from 2026 to 2035.

According to Precedence Research, the introduction of SONNET 3 will help to modernize and expand the cochlear implant market. This audio processor is small in size and lightweight, and is equipped with various advanced digital technologies that enable the user to listen to music from their electronic devices. It also features the Automatic Sound Management (ASM 3.0) technology developed by the company, which allows the processor to adjust audio parameters and suppress background noise to help the user focus on the conversation.

Impact on the Digital Transformation Market

The global digital transformation market size accounted for USD 1.49 trillion in 2025 and is predicted to reach around USD 12.53 trillion by 2035, growing at a CAGR of 23.73% from 2026 to 2035.

According to Precedence Research, the launch of SONNET 3 represents a significant shift in terms of the adoption of digital technologies in cochlear implants. Conventional cochlear implants did not have features to place phone calls or stream music directly by connecting to the user's electronic device, but SONNET 3 does. Even if not essential, these features make extended-duration usage possible, as people get to have some entertainment as a reward for wearing the implant throughout the day.

Expert Opinion

Senior officials at MED-EL India said that this launch improves accessibility to advanced hearing technologies. They also said that technological enhancement alone will not ensure improvement in outcomes; there also needs to be timely diagnosis and appropriate treatment. The company places significant emphasis on supporting healthcare professionals, implant facilities, and the hearing-care ecosystem to improve their experience.

About MED-EL

MED-EL is a prominent medical technology manufacturer that provides hearing-care products and services. The company was founded in 1977, when the CEO, Dr. Ingeborg Hochmair, developed the modern cochlear implant along with her husband Erwin. MED-EL has its headquarters in Innsbruck, Austria, and the hearing solutions of the company have been adopted in more than 140 countries across the globe.

The audio processor lineup of the company includes RONDO 3, SONNET 3, SAMBA 2, and ADHEAR, and it also provides various hearing solutions such as cochlear implants, bone conduction hearing aids, bone conduction implants, active middle ear implants, and passive middle ear implants. MED-EL also has a science center in Innsbruck, Austria, where it conducts hearing and special exhibitions.